Vegas, Arturo J
Veiseh, Omid
Gürtler, Mads
Millman, Jeffrey R
Pagliuca, Felicia W
Bader, Andrew R
Doloff, Joshua C
Li, Jie
Chen, Michael https://orcid.org/0000-0002-1590-768X
Olejnik, Karsten
Tam, Hok Hei
Jhunjhunwala, Siddharth
Langan, Erin
Aresta-Dasilva, Stephanie
Gandham, Srujan
McGarrigle, James J
Bochenek, Matthew A
Hollister-Lock, Jennifer
Oberholzer, Jose
Greiner, Dale L
Weir, Gordon C
Melton, Douglas A
Langer, Robert
Anderson, Daniel G
Article History
Received: 28 October 2015
Accepted: 14 December 2015
First Online: 25 January 2016
Change Date: 18 February 2016
Change Type: Corrigendum
Change Details: In the version of this article initially published online, the authors omitted acknowledgment recognizing the histology core of the Harvard Stem Cell Institute and several individuals for their assistance. The error has been corrected for the print, PDF and HTML versions of this article.
Competing interests
: F.W.P., J.R.M., M.G. and D.A.M. declare a financial interest via a patent filed by Harvard University and HHMI on the production of stem cell–derived β-cells. A.J.V., O.V., J.C.D., R.L. and D.G.A. declare financial interests via patents filed by MIT on the material and hydrogel capsule technology.